SP1 and tick-borne encephalitis: 2014). As the immune‐modulator fingolimod, which inhibits S1P signaling, leads to an increase in parasympathetic regulation in humans (Simula et al. 2015), elevation of SP1 in TBE could be an explanation for the predominant sympathetic innervations in our TBE patients.